Pluribus Labs’s Ormat Technologies ORA Stock Holding History

Pluribus Labs’s Portfolio ORA Stock Details ORA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,198	Closed	-$412K	–	171
2021 Q4	$412K	Buy	+5,198	New	+$392K	0.43%	74

Other funds holding ORA

ORIX Corp Tokyo, Japan $36.6M AUM 25.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Pluribus Labs's ORA Position: Q1 2022 in Review

Pluribus Labs sold out of Ormat Technologies (ORA) in Q1 2022, closing a stake of 5,198 shares — an estimated $412K sold.

Pluribus Labs first reported a position in ORA in Q4 2021 and held it in 1 quarter. The position peaked at $412K in Q4 2021. 232 funds tracked by Wall St. Rank hold ORA as of Q1 2022.

Pluribus Labs reported no remaining Ormat Technologies position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 5,198 Ormat Technologies shares in Q1 2022, an estimated $412K.
Pluribus Labs first reported a position in Ormat Technologies in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Ormat Technologies position peaked at $412K in Q4 2021.
232 funds tracked by Wall St. Rank held Ormat Technologies as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.